Nika Pharmaceuticals Inc (NIKA) Stock Price & Analysis
NIKA Stock Chart & Stats
- Day’s Range
- $0.35 - $0.40
- 52-Week Range
- $0.20 - $0.98
- Previous Close
- $0.35
- Volume
- N/A
- Average Volume (3M)
- 153
- Market Cap
- $368.09M
- Enterprise Value
- $534.55T
- Total Cash (Recent Filing)
- $2,932
- Total Debt (Recent Filing)
- $0
- Price to Earnings (P/E)
- ―
- Beta
- 0.39
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
NIKA FAQ
What was Nika Pharmaceuticals Inc’s price range in the past 12 months?
What is Nika Pharmaceuticals Inc’s market cap?
When is Nika Pharmaceuticals Inc’s upcoming earnings report date?
Is Nika Pharmaceuticals Inc overvalued?
Does Nika Pharmaceuticals Inc pay dividends?
What is Nika Pharmaceuticals Inc’s EPS estimate?
How many shares outstanding does Nika Pharmaceuticals Inc have?
Which hedge fund is a major shareholder of Nika Pharmaceuticals Inc?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Nika Pharmaceuticals Inc
Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious diseases including HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, and diabetes. The company's product line features antiviral treatments and nutritional supplements, notably providing a specialized thymus nuclear glycoprotein for the management of HIV. Originally established in 2000, the organization was previously known as Centennial Growth Equities Inc. before adopting its current name, Nika Pharmaceuticals, Inc., in May 2022.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dimitar Slavchev Savov
- Employees
- 0
- Website
- www.nikapharmaceuticals.com
- Address
- 2269 Merrimack Valley Avenue, Henderson, NV, 89044, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 1 | 14 |
| Technical Analysis | 6 | 1 | 2 |
| Moving Averages | 0 | 0 | 12 |
